Clinical Trial Update: Endostar Combined With Intensity-modulated Radiotherapy Compare With Chemoradiation for Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Endostar plus intensity-modulated radiotherapy to chemoradiation for nasopharyngeal carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Endostar (recombinant human endostatin)

Snippet

Sponsor: First Affiliated Hospital of Guangxi Medical University | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: COMPLETED